Pharmacology & ToxicologybioRxiv
The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy
K. Lima, D. A. Pereira-Martins, L. B. L. de Miranda…·J. A. Machado-Neto
This study shows that THZ-P1-2, a PIP4K2 inhibitor, kills leukemia cells by disrupting mitochondrial homeostasis and autophagy, with minimal effects on healthy cells.
DOI 10.1038/s41408-022-00747-w